Compare BridgeBio Pharma Inc (BBIO) vs Brunswick Corporation (BC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Brunswick Corporation — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Brunswick Corporation trades at $76.79 (market cap $5.00B). The key difference: BridgeBio Pharma Inc is far larger — about 3.3× Brunswick Corporation's market cap, and Brunswick Corporation pays a 2.29% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | BC | |
|---|---|---|
Market Cap | $16.27B | $5.00B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.17 | $89.22 |
52-Week Low | $44.81 | $56.64 |
Enterprise Value | $17.82B | $7.16B |
Dividend Yield | — | 2.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Brunswick Corporation
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →
